Healthy Volunteers Hv

13

Review clinical trials related to Healthy Volunteers Hv. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study to Assess the Absolute Bioavailability and How Adimanebart SC Moves Through the Body in Healthy Adult Participants

This study aims to find out how much adimanebart gets into the blood circulation of healthy adults. Researchers will measure the amount of adimanebart in blood over time to learn how it moves through the body. The drug's safety will also be assessed. The participants will be assigned to one of 3 parts of the study: part 1 investigates the absolute bioavailability; part 2 investigates the effect of different body weights on adimanebart in blood after subcutaneous (SC) dosing; part 3 investigates formulation adaptations. Participants will be in the study for approximately up to 24 weeks.

Participants needed: 52
Trial details
Phase: Phase 1Age: 18-65Biological sex: AllType: InterventionalSponsor: argenxUpdated: Jun 29, 2026Locations: 1
Eligibility criteria

Is at least the local legal age of consent and aged 18 to 65 years, inclusive, w... [+2]

Has any current or past clinically meaningful medical or psychiatric condition,... [+2]

Status: Recruiting

Electrical Nerve Stimulation During Sleep for Memory Consolidation

The purpose of this study is to investigate the effects of transcutaneous electrical nerve stimulation (eTNS) applied during sleep on memory consolidation and brain-body physiological coupling. Healthy college students will participate in four overnight sleep sessions in a standard sleep laboratory. Before going to sleep, participants will learn and complete two cognitive tasks: a motor sequence tapping task to assess procedural memory, and an N-back task to assess working memory. During the night, participants will receive either 2 Hz eTNS, 120 Hz eTNS, or a sham (placebo) stimulation on their forehead in a randomized order. Throughout the night, researchers will record their sleep using polysomnography (PSG), along with continuous monitoring of heart rate (ECG) and breathing (respiration). Upon waking the next morning, participants will be re-tested on both memory tasks. The primary objective is to determine whether eTNS during sleep can improve behavioral performance on procedural and working memory tasks overnight. Secondary objectives include analyzing the stimulation's effects on specific sleep brain wave patterns (such as slow oscillations and sleep spindles) and exploring the coupling mechanisms between brain activity, heart rhythms (Heartbeat Evoked Potentials), and respiration during sleep.

Participants needed: 30
Trial details
Age: 18-35Biological sex: AllType: InterventionalSponsor: Xidian UniversityUpdated: Jun 24, 2026Locations: 1
Eligibility criteria

Healthy young adults (e.g., college students), aged generally between 18 and 30... [+3]

History or current presence of neurological disorders, psychiatric disorders, or... [+8]

Status: Recruiting

A Single Dose, Phase 1 Study of JADE101 in Healthy Japanese and Chinese Participants

This is a Phase 1 study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of a single dose of JADE101 in healthy Japanese and Chinese participants.

Participants needed: 40
Trial details
Phase: Phase 1Age: 18-55Biological sex: AllType: InterventionalSponsor: Jade Biosciences, Inc.Updated: Jun 4, 2026Locations: 1
Eligibility criteria

Healthy male or female participants 18-55 years of age, inclusive [+4]

Harmful alcohol use [+6]

Status: Not yet recruiting

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of KR25102 in Healthy Volunteers

Phase 1 Single Ascending Doses(SAD): Six cohorts of 53 healthy volunteers (HVs) will receive a single IV bolus injection of study drug or placebo. Phase 1 Multiple Ascending Doses(MAD): Three cohorts of 30 HVs will receive multiple IV bolus injections of study drug or placebo every day. After 7 days of continuous administration, the safety, tolerance and Pharmacokinetic/Pharmacodynamic characteristics of multiple administrations were evaluated.

Participants needed: 83
Trial details
Phase: Phase 1Age: 18-55Biological sex: AllType: InterventionalSponsor: Jiangxi Kvvit Pharmaceutical Co., Ltd.Updated: Jun 1, 2026Locations: 1
Eligibility criteria

Male and female participants aged between 18 and 55 years inclusive (as of the t... [+5]

Subjects with previous or current clinical acute or chronic diseases including b... [+10]

Status: Not yet recruiting

Assessment Of Signal Consistency Between Needle And Surface Electrodes In Tibialis Anterıor Muscle: A Pilot Validaton Study

The aim of this study is to evaluate whether surface electrodes can record physiological muscle activity as accurately as the gold-standard needle electrodes in the tibialis anterior muscle using a diagnostic EMG device The aim of this pilot study is to investigate whether muscle activation data, similar to surface electromyography (SEMG), can be obtained by adjusting the measurement and recording parameters of standard Electroneuromyography (EMG) devices used routinely for diagnostic purposes. Although SEMG is considered the gold standard for the objective assessment of muscle activation, its clinical use in our country is limited due to the high cost of specialized hardware and software. In contrast, diagnostic EMG devices are widely available in many healthcare institutions. The research will be conducted on 30 healthy volunteers between the ages of 20 and 60. Participants will undergo lower extremity nerve conduction studies, reflex response measurements, and muscle activation assessments during voluntary isometric contractions of the m. tibialis anterior. Muscle activation will be recorded using the diagnostic EMG device via surface (adhesive and Ag/AgCl coated) electrodes and needle electrodes. The acquired EMG signals will be analyzed in terms of RMS (Root Mean Square), amplitude, and frequency parameters. The procedures performed within the scope of this study are standard practices carried out during routine EMG examinations. The only additional procedure specific to this research is the repetition of muscle activation measurements using different electrode systems. There is no invasive procedure involved in the surface electrode applications, and the needle electrode application will be performed exactly as it is in routine EMG tests. No serious risks are anticipated; rarely, mild pain, redness, or minor bleeding at the needle insertion site may occur. Through this study, diagnostic EMG devices could be utilized more effectively in rehabilitation and treatment monitoring. It is intended to contribute to the reduction of invasive procedures and to establish a scientific foundation for clinical applications regarding the objective evaluation of muscle activation.

Participants needed: 30
Trial details
Age: 20-60Biological sex: AllType: InterventionalSponsor: Romatem Bursa HospitalUpdated: May 20, 2026
Eligibility criteria

20-60 years old [+1]

muscle disease [+5]

Status: Recruiting

Phase I Study of HXN6005 in Adult Healthy Participants

The goal of this clinical trial is to evaluate the safety, tolerability, pharmacokinetic characteristics and pharmacodynamics of HXN6005 in Healthy Participants. Researchers will compare HXN6005 to a placebo (a look-alike substance that contains no drug). Participants will take a single dose of HXN6005 or placebo on Day 1, and visit the clinic for followup and tests per the protocol scheme.

Participants needed: 32
Trial details
Phase: Phase 1Age: 18-55Biological sex: AllType: InterventionalSponsor: Helixon Biotechnology (Suzhou) Co., LtdUpdated: Apr 24, 2026Locations: 1
Eligibility criteria

Participants must sign an Institutional Review Board (IRB) approved informed con... [+6]

Females who are pregnant, planning to become pregnant, or lactating during the t... [+17]

Status: Not yet recruiting

Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Breast Cancer

The purpose of this research study is to test a new process for diagnosing breast cancer by examining changes to your DNA that can be detected from a blood test. The information we learn by doing this study could potentially help people in the future. Participants in this study will have blood samples collected, have their medical records reviewed by study personnel and fill out questionnaires at different time points during the study. Blood sample collection will occur during normal routine clinic visits. Participation in this study will last approximately 5 years.

Participants needed: 450
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University of Maryland, BaltimoreUpdated: Apr 22, 2026Locations: 1
Eligibility criteria

18 years old or older [+3]

Younger than 18 years old [+3]

Status: Not yet recruiting

Drug-Drug Interaction Study of MDR-001 With Rifampin and Itraconazole in Healthy Adult Participants

A Phase I, open-label, fixed-sequence, two-part drug-drug interaction study in healthy Chinese adults to evaluate the effect of multiple-dose rifampin (Part A) or itraconazole (Part B) on the single-dose pharmacokinetics of MDR-001, an oral GLP-1 receptor agonist.

Participants needed: 28
Trial details
Phase: Phase 1Age: 18-55Biological sex: AllType: InterventionalSponsor: MindRank AI LtdUpdated: Apr 24, 2026Locations: 1
Eligibility criteria

Voluntary participation and signed informed consent before any study procedures,... [+5]

Average daily smoking >5 cigarettes within 3 months before dosing. [+24]

Status: Recruiting

Research Into the Safety of a New Agent (VT-5006) in People With and Without Parkinson's Disease

This is a first-in-human (FIH) study of orally administered VT-5006 (also known as AX-5006) in healthy adult volunteers (HVs) and adult participants with Parkinson's disease (PD). The goal of this clinical trial is to learn if VT-5006 is safe and tolerable in healthy volunteers and in participants with PD. It has three Parts (A, B, and C). Part A: Healthy volunteers aged 18-54 will attend a screening visit, take a single dose of VT-5006 or matching placebo after an overnight fast, stay in the clinic for three nights, and complete a follow-up visit. One group of participants in Part A will be asked to return to the clinic after approximately two weeks, take a single dose of VT-5006 or matching placebo after consuming a high-fat meal and stay in the clinic for another three nights. Part B: Healthy volunteers aged 18-54 will attend a screening visit, take one dose of VT-5006 or matching placebo each day for seven days after fasting overnight, stay in the clinic for 10 nights, and complete a follow up visit. Part C: Participants with PD aged 40-80 will attend a screening visit, take one dose of VT-5006 (high dose), VT-5006 (low dose), or matching placebo each day for 28 days, complete two overnight stays in the clinic, attend three clinic visits, one phone call and a follow up visit.

Participants needed: 84
Trial details
Phase: Phase 1Age: 18-80Biological sex: AllType: InterventionalSponsor: Vertero TherapeuticsUpdated: Mar 20, 2026Locations: 1
Eligibility criteria

Diagnosed with PD confirmed by a neurologist within a maximum of 10 years (based... [+5]

Has a known allergy or hypersensitivity to any component of the formulation of V... [+6]

Status: Not yet recruiting

Effects of a Sleep Education Program on the Health Status of Healthcare Workers Working 12-hour Alternating Day-night Shifts

In a context of seeking a better balance between personal and professional life and labor shortages, the use of 12-hour alternating day-night shifts has become more common in work organizations, particularly in healthcare facilities. This work pattern combines exposure to alternating day and night shifts with long working hours, raising questions about its effects on health, particularly sleep quality and cardiovascular risk. Staff working alternating day/night or night shifts are at risk of cardiovascular disease, particularly in connection with sleep deprivation and the adoption of individual behaviors that increase the risk (smoking, poor diet, alcohol consumption, smoking and low physical activity). However sleep education is not integrated in a personalized way into the prevention advice provided by occupational health services. Therefore, this study aims to investigate the effects of a 6-month sleep education program conducted by occupational health nursing staff, on the sleep duration of healthcare workers newly exposed to alternating 12-hour day and night shifts.

Participants needed: 160
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: Centre Hospitalier Universitaire de Saint EtienneUpdated: Mar 13, 2026Locations: 3
Eligibility criteria

Being a paramedical caregiverr (nurse or care assistant) [+5]

Nursing staff and nursing assistants who have been exposed for more than six mon... [+5]

Status: Not yet recruiting

Examining the Effects of Reformer Pilates Exercises on Physical Fitness and Cognitive Functions in Healthy Individuals

Pilates is an exercise method that aims to increase body awareness and improve physical fitness through controlled movements based on mind-body integration. Reformer Pilates strengthens the mind-body connection while increasing core muscle activation through equipment-assisted exercises. It is known that regular exercise has positive effects on cognitive functions through its neuroprotective and neuroplastic effects. However, the effects of Reformer Pilates on these functions have been studied in only a limited number of studies, particularly in healthy middle-aged individuals. The aim of this project proposal is to investigate the effectiveness of Reformer Pilates exercises on physical fitness and cognitive functions in healthy individuals. In this study, the effects of reformer Pilates on physical fitness and cognitive functions will be examined in healthy individuals aged 18-50. The intervention group will perform reformer Pilates twice a week for 8 weeks, while the control group will not participate in any physical activity. Body mass index, waist-to-height ratio, waist-to-hip ratio, cognitive reserve, cognitive functions, reaction time, physical fitness, grip strength, and general health status will be assessed at baseline and after 8 weeks. Cognitive functions will be assessed using the cognitive reserve index, and cognitive functions will be assessed using the Stroop test-anchor form and the tracking test. Stroop test-anchor form and tracking test; reaction time will be measured using a wireless system consisting of a laser LED light emitter and a central hand control unit; physical fitness will be assessed using The Senior Fitness Test; grip strength will be measured using a hand dynamometer; and general health status will be assessed using the General Health Questionnaire-12. Data analysis will be performed using SPSS version 25.0. For comparing pre- and post-treatment outcome measures within the group, analysis will be conducted using the t-test for dependent samples (if normally distributed) or the Wilcoxon signed-rank test (if not normally distributed). Effect size will be calculated to determine the impact of the exercise program. P\<0.05 will be considered statistically significant.

Participants needed: 42
Trial details
Age: 18-50Biological sex: FemaleType: InterventionalSponsor: Inonu UniversityUpdated: Aug 21, 2025
Eligibility criteria

Individuals who do not have a regular exercise habit, [+2]

Individuals with a history of serious musculoskeletal or neurological disease, [+5]

Status: Recruiting

Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Lung Cancer

The purpose of this research study is to test a new process for diagnosing lung cancer by examining changes to your DNA that can be detected from a blood test. The information we learn by doing this study could potentially help people in the future. Participants in this study will have blood samples collected, have their medical records reviewed by study personnel and fill out questionnaires at different time points during the study. Blood sample collection will occur during normal routine clinic visits. Participation in this study will last approximately 5 years.

Participants needed: 750
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University of Maryland, BaltimoreUpdated: Jun 11, 2025Locations: 1
Eligibility criteria

18 years old or older [+3]

Younger than 18 years old [+3]

Status: Not yet recruiting

Effects of Integrative Neuromuscular Traning on Physical Fitness and Dribbling Performance Among High School Male Football Players in Shandong, China

This study investigates the effects of a 12-week Integrative Neuromuscular Training (INT) program on physical fitness, balance, and dribbling skills in male high school soccer players in Shandong, China. INT, which combines strength, agility, balance, core stability, and proprioception, has been shown internationally to enhance athletic performance and prevent injuries among youth athletes. While widely applied in sports like basketball, volleyball, and swimming abroad, research on INT in Chinese male soccer players remains limited. A total of 60 male soccer players (aged 16-18) with at least two years of training experience will be recruited from two high schools in Jinan and divided equally into experimental and control groups. The experimental group will undergo INT three times per week for 12 weeks, while the control group will continue regular soccer training. The study will measure changes in strength, speed, endurance, flexibility, static and dynamic balance, and dribbling performance. Data collection spans 16 weeks, including pre-tests, intervention, and post-tests. Statistical analysis will be conducted using SPSS 26.0, employing descriptive statistics, GEE models, and repeated measures ANOVA. This research aims to provide scientific evidence for the use of INT in youth soccer training in China.

Participants needed: 70
Trial details
Age: 16-18Biological sex: MaleType: InterventionalSponsor: Xinrui ZhangUpdated: Jun 12, 2025Locations: 1
Eligibility criteria

Male high school football players aged between 16 to 18 years [+4]

History of significant musculoskeletal injuries (e.g., knee, ankle, or hip injur... [+4]